1367-P: Type 2 Diabetes Mellitus and Obesity Amplifies Nonalcoholic Fatty Liver Disease Risk with Age

1367-P: Type 2 Diabetes Mellitus and Obesity Amplifies Nonalcoholic Fatty Liver Disease Risk with Age

Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent in the general population with multiple known metabolic risk factors. There is limited evidence on the impact of age on the prevalence of hepatic steatosis and fibrosis, and their relationship to cardiometabolic risk factors...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2023-06, Vol.72 (Supplement_1), p.1
Hauptverfasser: SHARMA, ANU, GODINEZ LEIVA, EDDISON, LOMONACO, ROMINA, VALDEZ SAENZ, ENRIQUE, ORTIZ ROCHA, ANDREA, GONZALEZ, MARIA A., MARANGI, STEPHEN A., SHRESTHA, SULAV, SHETTY, SHWETHA S., BUDD, JEFFREY T., KALAVALAPALLI, SRILAXMI, BARB, DIANA, CUSI, KENNETH
Format: Artikel
Sprache:eng
Schlagworte:
Age groups
Antihypertensives
Diabetes
Diabetes mellitus (non-insulin dependent)
Dyslipidemia
Fatty liver
Fibrosis
Liver diseases
Middle age
Obesity
Risk factors
Statins
Steatosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent in the general population with multiple known metabolic risk factors. There is limited evidence on the impact of age on the prevalence of hepatic steatosis and fibrosis, and their relationship to cardiometabolic risk factors. To this end, we recruited 761 patients 35-75 years of age, with and without T2DM, who underwent screening for NAFLD with laboratory tests and imaging by elastography (steatosis by controlled attenuation parameter [CAP]; fibrosis by liver stiffness measurement [LSM]). Patients were divided into 3 age groups:
ISSN:0012-1797
1939-327X
DOI:10.2337/db23-1367-P